Taken together, these data indicated that the PTEN, AKT1, MDM2 and p53 tumor suppressor-oncoprotein network is genetically heterogeneous, a feature that can lead to a wide variation in the p53 response and may ultimately influence cancer risk [25]. Here, PTEN is linked to cancer.